1. Services

Services under consideration for future development include:

• online algorithms for clinical care
• guidelines for shared Rheumatoid Arthritis patient care (GP and Rheumatologist)
• online referral forms to assist in management
• online profiles of commonly prescribed anti-rheumatic drugs detailing possible side effects and immediate management advice for suspected reactions including a free advice hotline.

2. ArthroCare Biotechnology

Through its subsidiary ArthroCare Biotechnology, ArthroCare Pty Ltd will establish a robust research and development program, which will seek to invent, develop, validate and bring to market across the globe, innovative, safe, affordable and wherever possible, substantially curative medications for the treatment of Rheumatoid and other painful and debilitating forms of arthritis. In some cases these products will be developed by genetic engineering technology. ArthroCare Biotechnology will ensure that when negotiating licensing agreements for its products, provision will be made for commercial products to be subsidized when supplied to developing countries, so that irrespective of geographic location, no patient with any serious form of arthritis will be significantly disadvantaged.

Collaborating Scientists:

Professor John Hamilton, Department of Medicine, University of Melbourne, Victoria

Associate Professor Helen Chapman, Division of Veterinary and Biomedical Sciences, Murdoch University, Western Australia

Dr Jalal Jazayeri, Senior Lecturer, Victorian College of Pharmacy, Monash University, Victoria

Dr Michael Bell, Department of Haematology, Sir Charles Gairdner Hospital, Western Australia

Dr Jenny Mills, Clinical Pathologist, Division of Veterinary and Biomedical Sciences, Murdoch University, Western Australia.